Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora M Hagelberg

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Opinion in Anaesthesiology|April 17, 2009
Oxycodone: new 'old' drugKlaus T Olkkola, Nora M Hagelberg
Clinical Pharmacokinetics|March 31, 2016
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain TherapyMarko A Peltoniemi, Nora M Hagelberg, Klaus T Olkkola, et al.
Scandinavian Journal of Pain|June 20, 2018
The association between physicians' attitudes to psychosocial aspects of low back pain and reported clinical behaviour: A complex issueAnna L Valjakka, Sanna Salanterä, Aarno Laitila, et al.
Journal of Clinical Psychopharmacology|April 22, 2011
Inhibition of cytochrome P450 3A by clarithromycin uniformly affects the pharmacokinetics and pharmacodynamics of oxycodone in young and elderly volunteersAntti Liukas, Nora M Hagelberg, Kristiina Kuusniemi, et al.
British Journal of Clinical Pharmacology|July 21, 2010
Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 aloneJuha Grönlund, Teijo I Saari, Nora M Hagelberg, et al.
Clinical Drug Investigation|December 15, 2010
Effect of inhibition of cytochrome P450 enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone: a randomized, three-phase, crossover, placebo-controlled studyJuha Grönlund, Teijo I Saari, Nora M Hagelberg, et al.
European Journal of Clinical Pharmacology|January 31, 2012
S-ketamine concentrations are greatly increased by grapefruit juiceMarko A Peltoniemi, Teijo I Saari, Nora M Hagelberg, et al.
Fundamental & Clinical Pharmacology|June 4, 2011
St John's wort greatly decreases the plasma concentrations of oral S-ketamineMarko A Peltoniemi, Teijo I Saari, Nora M Hagelberg, et al.
European Journal of Clinical Pharmacology|January 16, 2010
Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodoneTeijo I Saari, Juha Grönlund, Nora M Hagelberg, et al.
European Journal of Clinical Pharmacology|August 11, 2010
Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavirTuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Opinion in Anaesthesiology|April 17, 2009
Oxycodone: new 'old' drugKlaus T Olkkola, Nora M Hagelberg
Clinical Pharmacokinetics|March 31, 2016
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain TherapyMarko A Peltoniemi, Nora M Hagelberg, Klaus T Olkkola, et al.
Scandinavian Journal of Pain|June 20, 2018
The association between physicians' attitudes to psychosocial aspects of low back pain and reported clinical behaviour: A complex issueAnna L Valjakka, Sanna Salanterä, Aarno Laitila, et al.
Journal of Clinical Psychopharmacology|April 22, 2011
Inhibition of cytochrome P450 3A by clarithromycin uniformly affects the pharmacokinetics and pharmacodynamics of oxycodone in young and elderly volunteersAntti Liukas, Nora M Hagelberg, Kristiina Kuusniemi, et al.
British Journal of Clinical Pharmacology|July 21, 2010
Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 aloneJuha Grönlund, Teijo I Saari, Nora M Hagelberg, et al.
Clinical Drug Investigation|December 15, 2010
Effect of inhibition of cytochrome P450 enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone: a randomized, three-phase, crossover, placebo-controlled studyJuha Grönlund, Teijo I Saari, Nora M Hagelberg, et al.
European Journal of Clinical Pharmacology|January 31, 2012
S-ketamine concentrations are greatly increased by grapefruit juiceMarko A Peltoniemi, Teijo I Saari, Nora M Hagelberg, et al.
Fundamental & Clinical Pharmacology|June 4, 2011
St John's wort greatly decreases the plasma concentrations of oral S-ketamineMarko A Peltoniemi, Teijo I Saari, Nora M Hagelberg, et al.
European Journal of Clinical Pharmacology|January 16, 2010
Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodoneTeijo I Saari, Juha Grönlund, Nora M Hagelberg, et al.
European Journal of Clinical Pharmacology|August 11, 2010
Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavirTuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Pageof 3